Compass Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2018 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Compass Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2018 to Q4 2022.
  • Compass Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2022 was $0.000, a 100% decline year-over-year.
  • Compass Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2022 was $0.000, a 100% decline year-over-year.
  • Compass Therapeutics, Inc. annual Interest Expense for 2022 was $0.000, a 100% decline from 2021.
  • Compass Therapeutics, Inc. annual Interest Expense for 2021 was $370K, a 59.3% decline from 2020.
  • Compass Therapeutics, Inc. annual Interest Expense for 2020 was $908K, a 26.1% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $0 $0 -$39K -100% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-15
Q3 2022 $39K $0 -$78K -100% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $117K $0 -$111K -100% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-01
Q1 2022 $228K $0 -$142K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $370K $39K -$139K -78.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $509K $78K -$134K -63.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $643K $111K -$131K -54.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-01
Q1 2021 $774K $142K -$134K -48.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $908K $178K +$177K +12227% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 $731K $212K -$100K -32.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $831K $242K -$72K -22.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $903K $276K +$275K +26136% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $628K $1.44K +$569 +65% Oct 1, 2019 Dec 31, 2019 10-Q 2020-02-14
Q3 2019 $628K $312K +$311K +40367% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $317K $314K +$313K +54038% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $3.28K $1.05K Jan 1, 2019 Mar 31, 2019 10-K 2020-06-08
Q4 2018 $875 Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 $771 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $580 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.